Novo’s end-stage hypertension trial drug fails, $817m impairment loss
Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss
Drugs
Health
Pharma
Drugs
Health
Pharma
Alcohol claims 2.6 million lives yearly, 209m people are dependent: WHO
About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according
Drugs
Health
Pharma
Global fight against trans fats proving successful as more nations join: UN
Fifty-three nations have adopted best practice policies to eliminate trans fats in foods — benefitting 46% of the world’s population, or about 3.7
Drugs
Health
Pharma
Teva to sell generic version of Novo Nordisk’s diabetic drug in US
Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.
Drugs
Health
Pharma
Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic
Drugs
Health
Pharma
FDA gives nod to Bristol Myer’s colorectal cancer therapy
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated
Drugs
Health
Pharma
Eli Lilly’s Zepbound resolves sleep apnea in more than half of trial patients
Tirzepatide, an obesity drug of Eli Lilly and Company, has helped resolve moderate-to-severe obstructive sleep apnea in 52.% of adult patients in two
Climate
Health
Pharma
A third of world’s largest marine protected areas exploited: Study
A third of the world’s largest marine protected areas (MPAs) are indulging in destructive activities such as industrial fishing, a global study reveals.
Drugs
Health
Pharma
WHO issues medical alert on falsified weight-loss, diabetic drugs
The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by